<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662220/" ref="ordinalpos=690&amp;ncbi_uid=4921205&amp;link_uid=PMC3662220" image-link="/pmc/articles/PMC3662220/figure/F1/" class="imagepopup">Figure 1. MAPK and PI3K <span class="highlight" style="background-color:">Signaling</span> Pathways.  From: Novel zebrafish model reveals a critical role for mapk in lymphangiogenesis. </a></div><br /><div class="p4l_captionBody">VEGFR2 and R3 can stimulate MAPK and PI3K signaling pathways in vitro. Inhibitors CI-1040, BEZ235 (BEZ), and PTK787/ZK2222584 (PTK) were employed to target the MAPK pathway, the PI3K pathway, or both pathways, respectively.</div></div>